Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death

Ralf Baumann1, Carmen Casaulta, Dagmar Simon

  • 1Department of Pharmacology, University of Bern, Switzerland.

Insights

Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that prevents neutrophil death. This finding suggests MIF plays a role in infectious diseases by prolonging neutrophil survival.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Macrophage migration inhibitory factor (MIF) is a known pro-inflammatory cytokine.
  • MIF activates macrophages and T cells.
  • Neutrophil apoptosis is crucial for resolving inflammation and preventing tissue damage.

Purpose of the Study:

  • To investigate the effect of MIF on neutrophil apoptosis.
  • To elucidate the molecular mechanisms by which MIF influences neutrophil survival.
  • To explore the potential role of MIF in cystic fibrosis.

Main Methods:

  • Recombinant MIF was used to treat human neutrophils in vitro.
  • Western blotting was employed to assess the cleavage of Bcl-2 family proteins (Bid, Bax).
  • Mitochondrial assays measured the release of cytochrome c and Smac.
  • Caspase-3 activity was quantified.
  • MIF plasma levels were measured in patients with cystic fibrosis.

Main Results:

  • Recombinant MIF significantly delayed neutrophil apoptosis in a dose- and time-dependent manner.
  • MIF inhibited the cleavage of proapoptotic proteins Bid and Bax.
  • MIF prevented the release of cytochrome c and Smac from mitochondria.
  • MIF suppressed caspase-3 activation.
  • Elevated MIF plasma levels were observed in cystic fibrosis patients.

Conclusions:

  • MIF acts as a survival factor for human neutrophils.
  • MIF inhibits apoptosis through pathways involving mitochondria and caspase activation.
  • Increased MIF levels in cystic fibrosis suggest a role in delayed neutrophil apoptosis in this disease.
  • These findings have potential implications for managing infectious diseases.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...